We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+24.75%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$757M
AUM Growth
+$293M
Cap. Flow
+$210M
Cap. Flow %
27.7%
Top 10 Hldgs %
37.11%
Holding
384
New
211
Increased
9
Reduced
13
Closed
104

Sector Composition

Rank Sector Weight
1 Healthcare 30.35%
2 Financials 10.57%
3 Consumer Discretionary 9%
4 Technology 5.91%
5 Industrials 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHAQ.WS
226
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
$149K 0.02%
150,000
BNGOW
227
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$148K 0.02%
70,621
SNPR.WS
228
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$142K 0.02%
+49,999
New +$113K
CPSR.WS
229
DELISTED
Capstar Special Purpose Acquisition Corp. Warrants, each whole warrant exercisable for one share of
CPSR.WS
$141K 0.02%
99,999
TMPOW
230
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$139K 0.02%
99,999
KSMTW
231
DELISTED
Kismet Acquisition One Corp Warrant
KSMTW
$137K 0.02%
+125,000
New +$111K
STWOW
232
DELISTED
ACON S2 Acquisition Corp Warrant
STWOW
$136K 0.02%
+83,331
New +$109K
EVGOW
233
DELISTED
EVgo Inc Warrants
EVGOW
$134K 0.02%
+74,999
New +$120K
DEH.WS
234
DELISTED
D8 Holdings Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exer
DEH.WS
$131K 0.02%
124,999
JSPRW icon
235
Japer Therapeutics Warrants
JSPRW
$149K
$127K 0.02%
87,500
APSG.WS
236
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$125K 0.02%
+66,664
New +$105K
VYGG.WS
237
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$124K 0.02%
+59,998
New +$109K
FAII.WS
238
DELISTED
Fortress Value Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class
FAII.WS
$123K 0.02%
+49,999
New +$84.2K
GRSVW
239
DELISTED
Gores Holdings V, Inc. Warrant
GRSVW
$121K 0.02%
+59,998
New +$87.2K
AVAN.WS
240
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$113K 0.01%
+74,998
New +$88K
BSN.WS
241
DELISTED
Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share
BSN.WS
$112K 0.01%
+99,999
New +$88.9K
BTWNW
242
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$110K 0.01%
+24,998
New +$91.6K
TALKW
243
DELISTED
Talkspace Inc Warrant
TALKW
$108K 0.01%
62,499
HPX.WS
244
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$107K 0.01%
99,999
FCACW
245
DELISTED
Falcon Capital Acquisition Corp. Warrant
FCACW
$107K 0.01%
+49,998
New +$87.4K
MAPSW
246
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$105K 0.01%
31,957
GHIVW
247
DELISTED
Gores Holdings IV, Inc. Warrant
GHIVW
$104K 0.01%
24,999
SEAH.WS
248
DELISTED
Sports Entertainment Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one s
SEAH.WS
$101K 0.01%
+74,999
New +$98.1K
XOSWW
249
Xos Inc Warrants
XOSWW
$10.5K
$99K 0.01%
+66,665
New +$102K
ASAQ.WS
250
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
$99K 0.01%
+90,000
New +$66.2K

Similar funds

Monashee Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Monashee Investment Management held 384 positions worth $757M, up 63% from $464M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management deployed $210M of net new capital in Q4 2020, opening 211 new positions and adding to 9 existing holdings. Its largest new stake was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $38.1M trimmed.

  • Monashee Investment Management's largest Q4 2020 buy was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.
  • Monashee Investment Management added most to Quanterix in Q4 2020, an estimated $8.95M increase.
  • Monashee Investment Management's biggest Q4 2020 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $38.1M.
  • Monashee Investment Management fully exited Caesars Entertainment in Q4 2020, selling an estimated $18.8M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $757M portfolio in Q4 2020.
  • Monashee Investment Management opened 211 new positions and closed 104 in Q4 2020.
  • Monashee Investment Management's portfolio value rose 63% quarter-over-quarter to $757M.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.